Julia Lopez

Last night, US pharmaceutical giant Merck cancelled the construction of a £1 billion drug research centre in the Prime Minister’s constituency. Eight hundred jobs that were going to be provided have now evaporated; 125 scientists were to be employed—no longer. The message from Merck executives was unsparing: simply put, the UK is not internationally competitive. The Government must wake up now. If AstraZeneca’s announcement on investment was the canary in the mine for UK life sciences, last night’s announcement should be a klaxon sounding across Whitehall. Will the Minister assure us that he is arranging urgent meetings with Health, Business and Treasury Ministers today? The facility was going to specialise in diseases like Alzheimer’s, Parkinson’s and multiple sclerosis. It was going to feed into the work of a cluster of life sciences bodies, such as the Francis Crick Institute. Did the Government engage with Merck before its decision? What damage will this cause to research and medicine access for our constituents who are affected by those conditions? The Government told UK taxpayers that their devastating national insurance hike would boost the NHS, but NHS leaders admit that the money has gone on national insurance, wage deals and drug price inflation, not better services, and there is no money left for negotiations with life sciences companies. In fact, life sciences have faced a £1.6 billion tax bill and a real-terms cut to research and development. What are Ministers in the Department for Science, Innovation and Technology doing to push the Health Secretary for progress on health data, advanced therapies, price negotiations and regulatory reform of the kind that will improve our life sciences offer? For the last year, Labour has dined out on deals secured by the last Conservative Government. We were promised that a US-UK trade deal would open doors for business. Instead, American firms are cancelling projects, and our ambassador, who should have been batting for Britain, was battling for survival. Now that Lord Mandelson has slinked away—again—who is speaking to the Americans about this collapsed deal? What will the Prime Minister be doing ahead of President Trump’s state visit to help UK life sciences? I welcome the Minister to his place, but where is the Secretary of State? In her very first week, she has overseen a £1 billion investment collapse. If she does not understand that this is the most important thing in her brief right now, and if the Government do not change course, it will not be the last deal to collapse.